Analytical Comparison of Methods for Extraction of Short Cell-Free DNA from Urine.
Ontology highlight
ABSTRACT: Urine cell-free DNA (cfDNA) is a valuable noninvasive biomarker for cancer mutation detection, infectious disease diagnosis (eg, tuberculosis), organ transplantation monitoring, and prenatal screening. Conventional silica DNA extraction does not efficiently capture urine cfDNA, which is dilute (ng/mL) and highly fragmented [30 to 100 nucleotides (nt)]. The clinical sensitivity of urine cfDNA detection increases with decreasing target length, motivating use of sample preparation methods designed for short fragments. We compared the analytical performance of two published protocols (Wizard resin/guanidinium thiocyanate and Q Sepharose), three commercial kits (Norgen, QIAamp, and MagMAX), and an in-house sequence-specific hybridization capture technique. Dependence on fragment length (25 to 1
SUBMITTER: Oreskovic A
PROVIDER: S-EPMC6854475 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA